Tumour-necrosis factor from the rabbit. II. Production by monocytes.

PubWeight™: 2.48‹?› | Rank: Top 2%

🔗 View Article (PMC 2009719)

Published in Br J Cancer on August 01, 1978

Authors

N Matthews

Articles citing this

Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res (1985) 5.22

Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci U S A (1985) 4.42

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proc Natl Acad Sci U S A (1983) 3.83

Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun (1980) 3.41

Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. Proc Natl Acad Sci U S A (1985) 2.92

Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol (1988) 2.66

Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells. Infect Immun (1980) 2.12

Tumour necrosis factor in synovial exudates. Ann Rheum Dis (1988) 2.09

Production of an anti-tumour cytotoxin by human monocytes. Immunology (1981) 1.78

Rabbit tumor necrosis factor: mechanism of action. Infect Immun (1981) 1.62

Tumour necrosis factor in man: clinical and biological observations. Br J Cancer (1987) 1.46

Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor. Proc Natl Acad Sci U S A (1986) 1.28

Production of an anti-tumour cytotoxin by human monocytes: comparison of endotoxin, interferons and other agents as inducers. Br J Cancer (1982) 1.28

Tumour-necrosis factor from the rabbit. III. Relationship to interferons. Br J Cancer (1979) 1.23

Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. Br J Cancer (1981) 1.13

Extinction of the tumor necrosis factor locus, and of genes encoding the lipopolysaccharide signaling pathway. J Exp Med (1993) 1.10

Physicochemical characterization of cytostatic factors released from human monocytes. Infect Immun (1982) 1.08

Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor. Proc Natl Acad Sci U S A (1983) 1.07

Effect of human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin. Immunology (1983) 1.07

Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect Immun (1993) 1.06

Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action. Br J Cancer (1983) 0.99

Absence of tumor necrosis factor-alpha in suction blister fluids and stratum corneum from patients with psoriasis. Arch Dermatol Res (1989) 0.88

Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib. Br J Cancer (2005) 0.88

Biology of TNFalpha and IL-10, and their imbalance in heart failure. Heart Fail Rev (2008) 0.87

Differential induction of cytolytic susceptibility by E1A, myc, and ras oncogenes in immortalized cells. J Virol (1989) 0.87

Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα. Nat Commun (2015) 0.85

Differences in tumour necrosis factor productive ability among rodents. Br J Cancer (1984) 0.83

Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease. Curr Opin Endocrinol Diabetes Obes (2014) 0.81

The LPS-induced neutrophil recruitment into rat air pouches is mediated by TNFalpha: likely macrophage origin. Mediators Inflamm (1997) 0.79

The cytostatic activity of cultured Kupffer cells. Br J Cancer (1985) 0.75

Articles by these authors

Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Br J Cancer (1978) 3.38

Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34

Production of an anti-tumour cytotoxin by human monocytes. Immunology (1981) 1.78

Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system. Br J Cancer (1976) 1.53

Tumour-necrosis factor from the rabbit. IV. Purification and chemical characterization. Br J Cancer (1980) 1.47

Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Thorac Surg (1991) 1.40

Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31

Production of an anti-tumour cytotoxin by human monocytes: comparison of endotoxin, interferons and other agents as inducers. Br J Cancer (1982) 1.28

Tumour-necrosis factor from the rabbit. III. Relationship to interferons. Br J Cancer (1979) 1.23

Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology (1993) 1.22

Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19

Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor. Immunology (1988) 1.17

Neutral amino acid uptake by the microvillous plasma membrane of the human placenta is inversely related to fetal size at birth in normal pregnancy. J Clin Endocrinol Metab (1998) 1.15

Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. Br J Cancer (1981) 1.13

Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Q J Med (1986) 1.12

Effect of human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin. Immunology (1983) 1.07

Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma. Br J Cancer (1975) 1.07

Immunogenicity of lipid-conjugated antigens. II. Anti-complementary activity and antigen trapping in the spleen. Immunology (1980) 1.04

pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J Biol Chem (1999) 1.01

Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action. Br J Cancer (1983) 0.99

Coeliac disease associated with auto-immune thyroiditis, Sjogren's syndrome, and a lymphocytotoxic serum factor. Aust N Z J Med (1972) 0.97

Human growth hormone in cultures of human pituitary tumors. J Neurosurg (1971) 0.97

A study of cell mediated and humoral immunity in haemophilia and related disorders. Br J Haematol (1985) 0.97

A case of hereditary combined deficiency of complement components C6 and C7 in man. Clin Exp Immunol (1989) 0.97

Smoking, humoral immunity, and ulcerative colitis. Gut (1991) 0.95

Tumour necrosis factor activity in joint fluids from rheumatoid arthritis patients. Br J Rheumatol (1989) 0.95

Zymosan-induced leukotriene B4 generation by human neutrophils is augmented by rhTNF-alpha but not chemotactic peptide. Immunology (1990) 0.94

Tumour cells which develop resistance to cytolysis by tumour necrosis factor have a different glycoform of a 105-kDa glycoprotein and lose the capacity to invade and metastasize. Int J Cancer (1990) 0.94

Recurrent meningococcal infections associated with a functional deficiency of the C8 component of human complement. Clin Exp Immunol (1980) 0.94

Lymphoid cell fractionation by aggregated immunoglobulin-agarose columns. J Immunol Methods (1976) 0.94

Fetuin: an acute phase protein in cattle. J Comp Physiol B (1992) 0.90

"Spontaneous" cytolysis by normal human lymphocytes of Burkitt's lymphoma cells of the EB2 cell line. Aust J Exp Biol Med Sci (1974) 0.90

Autoimmunity to collagen in adult periodontal disease: immunoglobulin classes in sera and tissue. J Periodontal Res (1992) 0.90

Human monocyte killing of tumor cells: contribution of an extracellular cytotoxin. Adv Exp Med Biol (1982) 0.88

Effect of serine/threonine kinase inhibitors on motility of human lymphocytes and U937 cells. Immunology (1994) 0.88

Production of hemopoietic growth factors and gamma-interferon by large granular lymphocytes from patients with T gamma lymphocytosis. Int J Cell Cloning (1987) 0.88

Antibodies to influenza A in a cluster of children with juvenile chronic arthritis. Br J Rheumatol (1988) 0.88

A simple, sensitive and reproducible assay for pyridoxal 5'-phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta (1999) 0.87

Cardiovascular and pulmonary function studies of a new sedative/analgetic (detomidine/Domosedan) for use alone in horses or as a preanesthetic. Acta Vet Scand Suppl (1986) 0.87

Characterisation of a new tryptic sub-fragment of human and rabbit IgG Fc fragment. Immunochemistry (1971) 0.86

Differential augmentation by recombinant human tumor necrosis factor-alpha of neutrophil responses to particulate zymosan and glucan. J Immunol (1990) 0.85

Chemical synthesis, expression and product assessment of a gene coding for biologically active human tumour necrosis factor alpha. Protein Eng (1989) 0.85

Inhibition of protein kinase C results in a switch from a non-motile to a motile phenotype in diverse human lymphocyte populations. Immunology (1995) 0.85

Active systemic lupus erythematosus is associated with the recruitment of naive/resting T cells. Br J Rheumatol (1996) 0.84

Tumour necrosis factor induction of ELAM-1 and ICAM-1 on human umbilical vein endothelial cells--analysis of tumour necrosis factor-receptor interactions. Cytokine (1992) 0.84

Chlamydia and Crohn's disease. Lancet (1979) 0.83

alpha 2HS-glycoprotein is expressed at high concentration in human fetal plasma and cerebrospinal fluid. Fetal Diagn Ther (1993) 0.82

Serum antibodies to anaerobic coccoid rods in patients with Crohn's disease or ulcerative colitis, and in medical and nursing staff. Br Med J (Clin Res Ed) (1981) 0.81

Motion rivalry impairs motion repulsion. Vision Res (2001) 0.81

Guillain-Barré syndrome associated with Campylobacter enteritis in a child. J Pediatr (1986) 0.81

Measurement of antibodies to Candida albicans as a screening test for humoral immunodeficiency. J Immunol Methods (1987) 0.81

Human monocyte cytotoxin is not identical with lymphoblastoid lymphotoxin. Eur J Immunol (1985) 0.80

Cardiopulmonary bypass and complement activation. Involvement of classical and alternative pathways. Anaesthesia (1982) 0.80

Antibody response to anaerobic coccoid rods in Crohn's disease. J Clin Pathol (1986) 0.80

Characterization of the normal lymphocyte population cytolytic to Burkitt's lymphoma cells of the EB2 cell line. Aust J Exp Biol Med Sci (1976) 0.79

Protein kinase C isotype expression and regulation of lymphoid cell motility. Immunology (1996) 0.79

A simple multistage field test for the prediction of anaerobic capacity in female games players. Br J Sports Med (2004) 0.79

Human neutrophil responses to pathogenic Escherichia coli are receptor-specific and selectively augmented by recombinant human tumor necrosis factor-alpha. J Infect Dis (1991) 0.79

Nitric oxide is produced during TNF killing of U937A cells but does not contribute to the cytotoxic process. Biochim Biophys Acta (1993) 0.79

Inducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras. J Exp Med (1991) 0.78

Agglutinins to anaerobic bacteria in Crohn's disease and in Indian patients with diarrhoea. J Med Microbiol (1984) 0.78

Anti-tumour cytotoxin from macrophages: no correlation between cytotoxin adsorption by tumour cell lines and their cytotoxin susceptibility. Immunology (1984) 0.78

Synthesis of the foetal protein fetuin by early developing neurons in the immature neocortex. J Neurocytol (1993) 0.78

Reduced levels of alpha-1-antitrypsin in children exposed to high levels of air pollution. Biol Neonate (1993) 0.77

Photographic and spectroscopic correlations of human cataracts. Ophthalmic Res (1989) 0.77

The selective augmentation by recombinant human tumour necrosis factor-alpha of neutrophil responses to pathogenic Escherichia coli. Immunology (1990) 0.77

Recurrent cerebral metastasis from a cardiac myxoma: case report and review of literature. Br J Neurosurg (2006) 0.77

Colonial morphology of tumour cells and susceptibility to cytolysis by tumour necrosis factor. The role of cellular fibronectin deposition in the extracellular matrix. Br J Cancer (1990) 0.75

Characterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumour system. Br J Cancer (1976) 0.75

Inhibition of K cell function by human breast cancer sera. Br J Cancer (1976) 0.75

Use of the defined antigen substrate spheres system as a model for analysing possible mechanisms of inhibition-blockade of anti-tumour lymphocytotoxicity. Immunology (1975) 0.75

Antimicrobial properties of preterm breast milk cells. Arch Dis Child (1983) 0.75

Zn-binding globulin in human fetal brain and liver: a marker for passive blood/CSF transfer of protein. Neuropathol Appl Neurobiol (1993) 0.75

Insertion of neonatal intercostal catheters. Crit Care Resusc (2003) 0.75

Bacterial identification using nitrocellulose blotting technique that incorporates ELISA to bacterial surface antigen. J Clin Pathol (1987) 0.75

Meningococcal infection and proteolytic control. J Clin Pathol (1978) 0.75

Buccal biopsy in diagnosis of Crohn's disease. Lancet (1979) 0.75

Antimicrobial effects of a macrophage-derived cytotoxin from the serum of BCG-primed rabbits (tumour necrosis serum). J Med Microbiol (1984) 0.75

Convulsions after miconazole overdose. Med J Aust (1987) 0.75

Immunofluorescence in cancer investigation and research. Ann N Y Acad Sci (1975) 0.75

Development of tumor cell resistance to tumor necrosis factor cytolysis results in reduced fibronectin binding and altered ganglioside expression. Cytokine (1991) 0.75

Serum and salivary immunoglobulin A and free secretory component in ulcerative colitis. Clin Allergy (1981) 0.75

Assessing a pregnant woman after trauma. Nursing (1990) 0.75

Meningococcal endocarditis with profound acquired hypocomplementaemia. J Infect (1985) 0.75

Bioequivalence of an ezetimibe/simvastatin combination tablet and coadministration of ezetimibe and simvastatin as separate tablets in healthy subjects. Int J Clin Pharmacol Ther (2006) 0.75

Glued to the bedside: staff veterans. Interview by Barbara Barzoloski-O'Connor. Nurs Spectr (Wash D C) (1995) 0.75

[Not Available]. Immunol Today (1984) 0.75

Letter: Spontaneous cytotoxic-activity as a test of human lymphocyte function. Lancet (1975) 0.75

Extremely low phase noise UHF oscillators utilizing high-overtone, bulk-acoustic resonators. IEEE Trans Ultrason Ferroelectr Freq Control (1992) 0.75

Mixed lymphocyte reaction supernatants exert varied effects upon gingival fibroblasts in vitro. J Clin Lab Immunol (1985) 0.75

Development of tumour cell resistance to tumour necrosis factor does not confer resistance to cytotoxic drugs. Eur J Cancer Clin Oncol (1989) 0.75

Continuous veno-venous hemodiafiltration using bicarbonate dialysate. Pediatr Nephrol (1997) 0.75